ClinPhenomics GmbH&Co. KG

Frankfurt am Main, Hesse 60596

0 studies enrolling now · 5 studies all time

What they study most

Chronic Kidney Disease, Dyslipidemia, Lipoprotein Disorder, Type 2 Diabetes, Type 2 Diabetes Mellitus, Type 2 Diabetes Treated With Insulin, Type2 Diabetes

Studies at this site

• A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes — Completed
• A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes — Completed
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections — Completed
• A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events — Completed